BrightSpring Health Services Inc’s recently made public that its 10% Owner KKR Group Partnership L.P. unloaded Company’s shares for reported $281.07 million on Jun 12 ’25. In the deal valued at $21.15 per share,13,288,101 shares were sold. As a result of this transaction, KKR Group Partnership L.P. now holds 79,671,883 shares worth roughly $1.81 billion.
Then, KKR Phoenix Aggregator L.P. sold 13,288,101 shares, generating $281,068,584 in total proceeds. Upon selling the shares at $21.15, the 10% Owner now owns 79,671,883 shares.
Before that, Phipps Jennifer A sold 15,616 shares. BrightSpring Health Services Inc shares valued at $339,648 were divested by the Chief Accounting Officer at a price of $21.75 per share. As a result of the transaction, Phipps Jennifer A now holds 230,030 shares, worth roughly $5.24 million.
TD Cowen initiated its BrightSpring Health Services Inc [BTSG] rating to a Buy in a research note published on June 23, 2025; the price target was $37. A number of analysts have revised their coverage, including CJS Securities’s analysts, who began to cover the stock in mid December with a ‘”a Market outperform”‘ rating. KeyBanc Capital Markets began covering BTSG with “Sector weight” recommendation on October 11, 2024. BTIG Research started covering the stock on June 21, 2024. It rated BTSG as “a Buy”.
Price Performance Review of BTSG
On Monday, BrightSpring Health Services Inc [NASDAQ:BTSG] saw its stock jump 2.25%% to $22.77. Over the last five days, the stock has gained 7.51%. BrightSpring Health Services Inc shares have risen nearly 116.44% since the year began. Nevertheless, the stocks have risen 33.71% over the past one year. While a 52-week high of $25.57 was reached on 06/09/25, a 52-week low of $10.15 was recorded on 01/10/25.
Levels Of Support And Resistance For BTSG Stock
The 24-hour chart illustrates a support level at 22.22, which if violated will result in even more drops to 21.67. On the upside, there is a resistance level at 23.16. A further resistance level may holdings at 23.55.
The most recent change occurred on March 06, 2024 when HSBC Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.
